Claraphi Advisory Network’s West Pharmaceutical WST Stock Holding History

Claraphi Advisory Network’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-550	Closed	-$226K	–	317
2022 Q1	$226K	Sell	550 -124	-18%	-$48.5K	0.07%	243
2021 Q4	$315K	Sell	674 -259	-28%	-$111K	0.11%	212
2021 Q3	$396K	Buy	933 +130	+16%	+$54.8K	0.14%	174
2021 Q2	$288K	Sell	803 -70	-8%	-$23.1K	0.09%	249
2021 Q1	$246K	Sell	873 -563	-39%	-$161K	0.07%	270
2020 Q4	$407K	Buy	1,436 +262	+22%	+$73.5K	0.11%	171
2020 Q3	$323K	Buy	+1,174	New	+$311K	0.12%	171
2020 Q2	–	Sell	-84	Closed	-$13K	–	1197
2020 Q1	$13K	Buy	+84	New	+$12.9K	0.01%	727

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Claraphi Advisory Network's WST Position: Q2 2022 in Review

Claraphi Advisory Network sold out of West Pharmaceutical (WST) in Q2 2022, closing a stake of 550 shares — an estimated $226K sold.

Claraphi Advisory Network first reported a position in WST in Q1 2020 and held it in 8 quarters. The position peaked at $407K in Q4 2020. 655 funds tracked by Wall St. Rank hold WST as of Q2 2022.

Claraphi Advisory Network reported no remaining West Pharmaceutical position as of Q2 2022 after selling out during the quarter.
Claraphi Advisory Network sold 550 West Pharmaceutical shares in Q2 2022, an estimated $226K.
Claraphi Advisory Network first reported a position in West Pharmaceutical in Q1 2020 and held it in 8 quarters.
Claraphi Advisory Network's West Pharmaceutical position peaked at $407K in Q4 2020.
655 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2022.

Based on Claraphi Advisory Network's 13F filing for Q2 2022, filed 19 Jul 2022.